Stux Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Stux Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$588K	Sell	4,000 -17,700	-82%	-$2.45M	0.08%	292
2014 Q1	$3.01M	Sell	21,700 -3,100	-13%	-$467K	0.37%	81
2013 Q4	$3.14M	Buy	24,800 +12,800	+107%	+$1.32M	0.37%	80
2013 Q3	$1.1M	Buy	12,000 +700	+6%	+$56.5K	0.15%	188
2013 Q2	$777K	Buy	+11,300	New	+$691K	0.1%	224

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stux Capital Management's JAZZ Position: Q2 2014 in Review

Stux Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 82% in Q2 2014, selling an estimated $2.45M and leaving 4,000 shares worth $588K. The position accounts for 0.08% of the portfolio, ranked #292.

Stux Capital Management first reported a position in JAZZ in Q2 2013 and has held it in 5 quarters since. The position peaked at $3.14M in Q4 2013. 305 funds tracked by Wall St. Rank hold JAZZ as of Q2 2014.

Stux Capital Management held 4,000 shares of Jazz Pharmaceuticals worth $588K as of Q2 2014.
Stux Capital Management sold 17,700 Jazz Pharmaceuticals shares in Q2 2014, an estimated $2.45M.
Jazz Pharmaceuticals made up 0.08% of Stux Capital Management's portfolio in Q2 2014, its #292 holding.
Stux Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 5 quarters since.
Stux Capital Management's Jazz Pharmaceuticals position peaked at $3.14M in Q4 2013.
305 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2014.

Based on Stux Capital Management's 13F filing for Q2 2014, filed 14 Jul 2014.